Pharma's Almanac TV
PA TV
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Roundtable
37 Articles Available
2
2
Can't find what you're looking for? Try our
advanced search
.
Q: What Challenges are Associated with Implementing Cloud Computing within CROs/CDMOs?
PAP-Q1-17-RT-004
Q: What Impact Do You Think the Move to Cloud Computing Will Have on the Ability of Contract Service Organizations to Better Meet the Needs of Their Customers?
PAP-Q1-17-RT-003
Q: What New Technology Introduced Within the Last Year Have You Found to Have the Most Impact on Your Business?
PAP-Q04-16-RT-001
Q: What is Your Perception of the State of Serialization in Your Sector of the Pharma Industry?
PAP-Q04-16-RT-003
Q: What Are You Doing to Become a Premier Outsourcing Partner in the Context of FDA’s Recent Shift to a Focus on Quality Culture Rather than Just Metrics?
PAP-Q04-16-RT-002
The FDA Recently Validated a Continuous Manufacturing Pharma Process Line—What Do You Think This Means for the Future?
PAP-Q03-16-RT-001
Q: With Respect to Supplier-Partner Relationships, What is Your Preferred Collaboration Model?
PAP-Q03-16-RT-003
Q: What Have You Found to be the Greatest Benefit from Close Collaboration Partnership Models?
PAP-Q03-16-RT-005
In Close Supplier-Partner Relationships, What Pitfalls Do You Try to Avoid? How Close is Too Close?
PAP-Q03-16-RT-004
Q: When it Comes to Processing, What Technology Will Have the Most Impact on Pharma Processing Over the Next 10 Years?
PAP-Q03-16-RT-002
Bioavailability: What Are Your Thoughts On Enhancing Bioavailability With Novel Technologies?
PAP-Q02-16-RT-001
Antibody-Drug Conjugate: Do We Understand The Capital Investment In Our Staff?
PAP-Q02-16-RT-003
Biosimilars: Are We on the Edge of a New Era of Biologics?
PAP-Q02-16-RT-002
«
2
2
